Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
A programme for prevention and treatment of resistant hypertension with alqorithm based therapy. Pathway. Subcontract Univ Of Cambridge. BHF Award.
Webb, David
(Principal Investigator)
Deanery of Clinical Sciences
Centre for Cardiovascular Science
Edinburgh Imaging
University of Edinburgh
Overview
Fingerprint
Research output
(1)
Project Details
Status
Finished
Effective start/end date
1/09/09
→
30/06/15
Funding
UK-based charities:
£122,510.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Aldosterone Release
Biochemistry, Genetics and Molecular Biology
100%
Systemic Vascular Resistance
Biochemistry, Genetics and Molecular Biology
100%
Primary Hyperaldosteronism
Pharmacology, Toxicology and Pharmaceutical Science
100%
Research output
Research output per year
2018
2018
2018
1
Article
Research output per year
Research output per year
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
forThe British Hypertension Society programme of Prevention And Treatment of Hypertension With Algorithm based Therapy (PATHWAY) Study Group
,
1 Jun 2018
,
In:
The Lancet Diabetes & Endocrinology.
6
,
6
,
p. 464-475
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Systemic Vascular Resistance
100%
Aldosterone Release
100%
Primary Hyperaldosteronism
100%